{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:26:51Z","timestamp":1791559611028,"version":"4.3.4"},"reference-count":24,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Gastric cancer is an aggressive malignancy characterized by high recurrence rates, even following curative resection. The Albumin\u2013Bilirubin (ALBI) score was originally established to assess hepatic functional reserve in patients with hepatocellular carcinoma (HCC). By reflecting both systemic inflammation and nutritional status, the ALBI score has demonstrated significant prognostic utility across a spectrum of solid malignancies. The present study aimed to evaluate the prognostic significance of the ALBI score in gastric cancer patients receiving adjuvant therapy after curative-intent resection. Materials and Methods: This retrospective study included 168 patients with gastric cancer who underwent curative-intent resection followed by adjuvant therapy between November 2008 and January 2021. ALBI scores were calculated from pre-treatment serum albumin and bilirubin levels. Patients were dichotomized into ALBI Grade 1 and ALBI Grade 2 based on an optimal ROC-derived cut-off value of \u22122.60. Survival outcomes, including overall survival (OS) and recurrence-free survival (RFS), were estimated using the Kaplan\u2013Meier method and compared via the log-rank test. Independent prognostic factors were identified using univariate and multivariate Cox proportional hazards regression models. Results: Of the 168 patients, 56.5% were classified as ALBI Grade 1 and 43.5% as ALBI Grade 2. ALBI Grade 2 was associated with significantly shorter median RFS (18.7 vs. 72.2 months; p = 0.001) and OS (40.7 vs. 104.3 months; p = 0.003). Multivariable analysis identified ALBI Grade 2 as an independent predictor for both poor OS (HR: 1.699, p = 0.010) and RFS (HR: 1.767, p = 0.004). Pathological stage III disease was also a significant independent prognostic factor for OS (HR: 3.024) and RFS (HR: 3.049) (all p = 0.010). Additionally, elevated CEA correlated with shorter RFS (p = 0.023). Conclusions: The ALBI score is a prognostic marker for both overall and recurrence-free survival in gastric cancer patients receiving adjuvant therapy. A lower ALBI score is associated with longer survival outcomes. The ALBI score may support postoperative risk stratification and individualized follow-up planning.<\/jats:p>","DOI":"10.3390\/medicina62020337","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T10:45:31Z","timestamp":1770633931000},"page":"337","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prognostic Significance of Albumin\u2013Bilirubin (ALBI) Score in Gastric Cancer Patients Undergoing Curative Resection Followed by Adjuvant Therapy"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9614-0651","authenticated-orcid":false,"given":"Talat","family":"Aykut","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Necmettin Erbakan University School of Medicine, Konya 42080, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4057-3108","authenticated-orcid":false,"given":"O\u011fuzhan","family":"Y\u0131ld\u0131z","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Necmettin Erbakan University School of Medicine, Konya 42080, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3414-5596","authenticated-orcid":false,"given":"Bahattin Engin","family":"Kaya","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Necmettin Erbakan University School of Medicine, Konya 42080, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Fuat","family":"G\u00fcrb\u00fcz","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Necmettin Erbakan University School of Medicine, Konya 42080, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0926-6748","authenticated-orcid":false,"given":"Mustafa","family":"Korkmaz","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Suleyman Demirel University School of Medicine, Isparta 32260, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3085-7964","authenticated-orcid":false,"given":"Mehmet Zahid","family":"Ko\u00e7ak","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Necmettin Erbakan University School of Medicine, Konya 42080, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melek","family":"Karakurt Ery\u0131lmaz","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Necmettin Erbakan University School of Medicine, Konya 42080, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4632-9501","authenticated-orcid":false,"given":"Murat","family":"Araz","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Necmettin Erbakan University School of Medicine, Konya 42080, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2335-3354","authenticated-orcid":false,"given":"Mehmet","family":"Arta\u00e7","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Necmettin Erbakan University School of Medicine, Konya 42080, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41571-023-00747-0","article-title":"Global burden of gastric cancer: Epidemiological trends, risk factors, screening and prevention","volume":"20","author":"Thrift","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.6004\/jnccn.2022.0008","article-title":"Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology","volume":"20","author":"Ajani","year":"2022","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/JCMA.0000000000000846","article-title":"The clinicopathological and genetic differences among gastric cancer patients with no recurrence, early recurrence, and late recurrence after curative surgery","volume":"86","author":"Chen","year":"2023","journal-title":"J. Chin. Med. Assoc."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.ijbiomac.2021.06.140","article-title":"Serum albumin levels and inflammation","volume":"184","author":"Sheinenzon","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Gremese, E., Bruno, D., Varriano, V., Perniola, S., Petricca, L., and Ferraccioli, G. (2023). Serum Albumin Levels: A Biomarker to Be Repurposed in Different Disease Settings in Clinical Practice. J. Clin. Med., 12.","DOI":"10.20944\/preprints202308.1613.v1"},{"key":"ref_6","first-page":"108062","article-title":"Bilirubin as a predictor of diseases of civilization. Is it time to establish decision limits for serum bilirubin concentrations?","volume":"6 672","year":"2019","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.4049\/jimmunol.181.3.1887","article-title":"Bilirubin possesses powerful immunomodulatory activity and suppresses experimental autoimmune encephalomyelitis","volume":"181","author":"Liu","year":"2008","journal-title":"J. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1159\/000494844","article-title":"Newly Proposed ALBI Grade and ALBI-T Score as Tools for Assessment of Hepatic Function and Prognosis in Hepatocellular Carcinoma Patients","volume":"8","author":"Hiraoka","year":"2018","journal-title":"Liver Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","article-title":"Assessment of liver function in patients with hepatocellular carcinoma: A new evidence-based approach-the ALBI grade","volume":"33","author":"Johnson","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_10","first-page":"841","article-title":"The albumin-bilirubin (ALBI) grade as a significant prognostic factor in colorectal cancer patients with liver metastases","volume":"3","author":"Demircan","year":"2019","journal-title":"J. Surg. Med."},{"key":"ref_11","first-page":"1941","article-title":"Assessment of pretreatment albumin-bilirubin grade in pancreatic cancer patients with liver metastasis","volume":"25","author":"Sakin","year":"2020","journal-title":"J. BUON"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e35069","DOI":"10.1097\/MD.0000000000035069","article-title":"Preoperative ALBI grade predicts mortality in patients undergoing curative surgery for pancreatic head cancer","volume":"102","author":"Azili","year":"2023","journal-title":"Medicine"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1245\/s10434-022-11654-6","article-title":"Prognostic Value of a Modified Albumin-Bilirubin Score Designed for Patients with Esophageal Squamous Cell Carcinoma After Radical Resection","volume":"29","author":"Shinozuka","year":"2022","journal-title":"Ann. Surg. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1186\/s13019-024-03311-8","article-title":"Prognostic value of albumin-bilirubin grade in lung cancer: A meta-analysis","volume":"19","author":"Jiang","year":"2024","journal-title":"J. Cardiothorac. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"100348","DOI":"10.1016\/j.esmoop.2021.100348","article-title":"Assessment of the albumin-bilirubin grade as a prognostic factor in patients with non-small-cell lung cancer receiving anti-PD-1-based therapy","volume":"7","author":"Takada","year":"2021","journal-title":"ESMO Open"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.21873\/anticanres.15887","article-title":"The Albumin\u2013Bilirubin Score Is a Prognostic Factor for Gastric Cancer Patients Who Receive Curative Treatment","volume":"42","author":"Ju","year":"2022","journal-title":"AntiCancer Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"11921","DOI":"10.2147\/CMAR.S279782","article-title":"Efficacy of the Preoperative Albumin\u2013Bilirubin Grade for Predicting Survival and Outcomes of Postoperative Chemotherapy for Advanced Gastric Cancer","volume":"12","author":"Zhu","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00268-017-4234-x","article-title":"Preoperative Albumin\u2013Bilirubin Grade Predicts Recurrences After Radical Gastrectomy in Patients with pT2-4 Gastric Cancer","volume":"42","author":"Kanda","year":"2018","journal-title":"World J. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/cts.13493","article-title":"Prognostic value of the preoperative albumin-bilirubin score among patients with stages I\u2013III gastric cancer undergoing radical resection: A retrospective study","volume":"16","author":"Wang","year":"2023","journal-title":"Clin. Transl. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1016\/j.transproceed.2019.08.027","article-title":"Application of the Albumin-Bilirubin Grade in Predicting the Prognosis of Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis","volume":"51","author":"Xu","year":"2019","journal-title":"Transplant. Proc."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.14701\/ahbps.2018.22.4.335","article-title":"Effectiveness of the albumin-bilirubin score as a prognostic factor for early recurrence after curative hepatic resection for hepatocellular carcinoma","volume":"22","author":"Lee","year":"2018","journal-title":"Ann. Hepatobiliary Pancreat. Surg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/17474124.2020.1748010","article-title":"ALBI versus child-pugh in predicting outcome of patients with HCC: A systematic review","volume":"22 14","author":"Peng","year":"2020","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_23","first-page":"e50949","article-title":"Albumin-Bilirubin (ALBI) Score and Systemic Immune-Inflammation Indexes Used as Pretreatment Outcome Predictors in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Robotic or Open Whipple Procedures: A Logistic Regression Analysis","volume":"15","author":"Mejia","year":"2023","journal-title":"Cureus"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1536\/ihj.21-080","article-title":"Association Between Albumin-Bilirubin Score at Admission and In-Hospital Mortality in Patients with Acute Heart Failure","volume":"62","author":"Kawata","year":"2021","journal-title":"Int. Heart J."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/2\/337\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T11:28:42Z","timestamp":1770636522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/2\/337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":24,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["medicina62020337"],"URL":"https:\/\/doi.org\/10.3390\/medicina62020337","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,7]]}}}